O	0	1	A
O	2	11	screening
O	12	20	approach
O	21	23	to
O	24	27	the
O	28	40	surveillance
O	41	43	of
O	44	52	patients
O	53	57	with
B-Disease	58	66	diabetes
O	67	70	for
O	71	74	the
O	75	83	presence
O	84	86	of
B-Disease	87	93	vision
I-Disease	93	94	-
I-Disease	94	105	threatening
I-Disease	106	117	retinopathy
O	117	118	.

O	120	122	To
O	123	130	provide
O	131	145	scientifically
O	146	151	based
O	152	161	screening
O	162	167	rules
O	168	171	for
O	172	175	the
O	176	183	primary
O	184	188	care
O	189	196	setting
O	197	205	designed
O	206	208	to
O	209	217	identify
O	217	218	,
O	219	226	through
O	227	237	evaluation
O	238	240	of
O	241	242	a
O	243	253	prescribed
O	254	257	and
O	258	265	limited
O	266	273	portion
O	274	276	of
O	277	280	the
B-Anatomy	281	290	posterior
I-Anatomy	291	297	fundus
O	297	298	,
O	299	304	those
O	305	313	patients
O	314	318	with
B-Disease	319	327	diabetes
O	328	331	who
O	332	336	have
B-Disease	337	348	retinopathy
O	349	355	severe
O	356	362	enough
O	363	365	to
O	366	370	need
O	371	379	referral
O	380	382	to
B-Anatomy	383	386	eye
O	387	391	care
O	392	403	specialists
O	403	404	.

O	405	418	Retrospective
O	419	427	analysis
O	428	430	of
O	431	434	the
B-Classification_system	435	440	Early
I-Classification_system	441	450	Treatment
I-Classification_system	451	459	Diabetic
I-Classification_system	460	471	Retinopathy
I-Classification_system	472	477	Study
O	478	479	(
B-Classification_system	479	484	ETDRS
O	484	485	)
O	486	498	photographic
O	499	503	data
O	504	508	base
O	508	509	.

O	510	513	The
B-Diagnostic_tool	514	520	fundus
I-Diagnostic_tool	521	533	photographic
O	534	541	grading
O	542	546	data
O	547	551	from
O	552	556	3711
O	557	565	patients
O	566	570	with
B-Disease	571	579	diabetes
O	580	588	enrolled
O	589	591	in
O	592	595	the
B-Classification_system	596	601	ETDRS
O	601	602	.

O	603	615	Multivariate
O	616	626	regression
O	627	637	techniques
O	638	642	were
O	643	647	used
O	648	650	to
O	651	659	identify
B-Symptom	660	671	retinopathy
I-Symptom	672	679	lesions
O	680	682	in
O	683	695	photographic
O	696	702	fields
O	703	704	1
O	704	705	,
O	706	707	2
O	707	708	,
O	709	710	3
O	710	711	,
O	712	714	or
O	715	716	a
O	717	728	combination
O	729	736	thereof
O	737	741	that
O	742	749	predict
B-Disease	750	763	proliferative
I-Disease	764	772	diabetic
I-Disease	773	784	retinopathy
O	785	786	(
B-Disease	786	789	PDR
O	789	790	)
O	791	793	or
B-Disease	794	804	clinically
I-Disease	805	816	significant
I-Disease	817	824	macular
I-Disease	825	830	edema
O	831	832	(
B-Disease	832	836	CSME
O	836	837	)
O	838	844	within
O	845	848	the
O	849	854	seven
O	855	863	standard
O	864	870	fields
O	870	871	.

O	872	877	These
O	878	882	were
O	883	887	used
O	888	890	to
O	891	900	construct
O	901	902	a
O	903	909	family
O	910	912	of
O	913	922	screening
O	923	928	rules
O	929	933	with
O	934	941	optimal
O	942	950	combined
O	951	962	sensitivity
O	963	966	and
O	967	978	specificity
O	979	981	on
O	982	987	which
O	988	990	to
O	991	995	base
O	996	1005	referrals
O	1006	1008	to
B-Anatomy	1009	1012	eye
O	1013	1017	care
O	1018	1029	specialists
O	1029	1030	.

O	1031	1039	Presence
O	1040	1042	of
B-Disease	1043	1051	moderate
I-Disease	1052	1054	to
I-Disease	1055	1061	severe
I-Disease	1062	1078	nonproliferative
I-Disease	1079	1087	diabetic
I-Disease	1088	1099	retinopathy
O	1100	1101	(
B-Disease	1101	1105	NPDR
O	1105	1106	)
O	1106	1107	,
B-Disease	1108	1111	PDR
O	1111	1112	,
O	1113	1115	or
B-Disease	1116	1120	CSME
O	1121	1123	in
O	1124	1130	graded
B-Diagnostic_tool	1131	1137	fundus
I-Diagnostic_tool	1138	1149	photographs
O	1149	1150	.

B-Symptom	1151	1162	Hemorrhages
I-Symptom	1163	1166	and
I-Symptom	1167	1181	microaneurysms
I-Symptom	1182	1183	(
I-Symptom	1183	1184	h
I-Symptom	1184	1185	/
I-Symptom	1185	1187	ma
I-Symptom	1187	1188	)
I-Symptom	1189	1197	temporal
I-Symptom	1198	1200	to
I-Symptom	1201	1204	the
I-Symptom	1205	1211	macula
O	1212	1213	(
O	1213	1225	photographic
O	1226	1231	field
O	1232	1233	3
O	1233	1234	)
O	1234	1235	,
O	1236	1238	as
O	1239	1245	severe
O	1246	1248	as
O	1249	1251	or
O	1252	1256	more
O	1257	1263	severe
O	1264	1268	than
B-Classification_system	1269	1274	ETDRS
O	1275	1283	standard
O	1284	1294	photograph
O	1295	1296	1
O	1297	1298	(
B-Symptom	1298	1299	h
I-Symptom	1299	1300	/
I-Symptom	1300	1302	ma
B-Dimension	1303	1304	3
I-Dimension	1306	1307	>
I-Dimension	1309	1311	or
I-Dimension	1312	1313	=
I-Dimension	1314	1315	3
O	1315	1316	)
O	1316	1317	,
O	1318	1328	identified
O	1329	1331	87
O	1331	1332	%
O	1333	1335	to
O	1336	1338	89
O	1338	1339	%
O	1340	1342	of
B-Anatomy	1343	1347	eyes
O	1348	1352	with
B-Disease	1353	1356	PDR
O	1357	1360	and
O	1361	1363	92
O	1363	1364	%
O	1365	1367	to
O	1368	1370	93
O	1370	1371	%
O	1372	1374	of
B-Anatomy	1375	1379	eyes
O	1380	1384	with
B-Disease	1385	1395	moderately
I-Disease	1396	1402	severe
I-Disease	1403	1405	to
I-Disease	1406	1412	severe
I-Disease	1413	1417	NPDR
O	1417	1418	,
O	1419	1424	which
O	1425	1428	are
O	1429	1431	at
O	1432	1436	high
O	1437	1441	risk
O	1442	1445	for
O	1446	1456	developing
B-Disease	1457	1460	PDR
O	1460	1461	.

O	1462	1475	Extrapolating
O	1476	1479	the
O	1480	1487	results
O	1488	1493	using
B-Disease	1494	1505	retinopathy
O	1506	1516	prevalence
O	1517	1521	data
O	1522	1526	from
O	1527	1540	epidemiologic
O	1541	1548	studies
O	1549	1552	for
O	1553	1556	the
O	1557	1564	general
B-Characteristic	1565	1570	older
I-Characteristic	1571	1576	onset
I-Characteristic	1577	1585	diabetic
I-Characteristic	1586	1596	population
O	1596	1597	,
O	1598	1601	the
O	1602	1612	calculated
O	1613	1624	sensitivity
O	1625	1628	for
O	1629	1638	detecting
B-Disease	1639	1642	PDR
O	1643	1645	on
O	1646	1647	a
O	1648	1654	single
O	1655	1666	examination
O	1667	1669	is
O	1670	1672	87
O	1672	1673	%
O	1673	1674	,
O	1675	1678	the
O	1679	1690	specificity
O	1691	1693	80
O	1693	1694	%
O	1694	1695	;
O	1696	1699	for
B-Disease	1700	1708	moderate
I-Disease	1709	1713	NPDR
O	1714	1716	or
O	1717	1722	worse
O	1722	1723	,
O	1724	1727	the
O	1728	1739	sensitivity
O	1740	1742	is
O	1743	1745	81
O	1746	1747	%
O	1747	1748	,
O	1749	1760	specificity
O	1761	1763	93
O	1763	1764	%
O	1764	1765	.

O	1766	1774	Applying
O	1775	1778	the
O	1779	1787	presence
O	1788	1790	of
B-Symptom	1791	1792	h
I-Symptom	1792	1793	/
I-Symptom	1793	1795	ma
B-Dimension	1796	1797	3
I-Dimension	1799	1800	>
I-Dimension	1802	1804	or
I-Dimension	1805	1806	=
I-Dimension	1807	1808	3
O	1809	1811	as
O	1812	1813	a
O	1814	1823	screening
O	1824	1828	rule
O	1829	1831	to
O	1832	1835	the
B-Characteristic	1836	1841	older
I-Characteristic	1842	1847	onset
I-Characteristic	1848	1858	population
O	1858	1859	,
O	1860	1862	26
O	1862	1863	.
O	1863	1864	5
O	1864	1865	%
O	1866	1868	of
O	1869	1877	patients
O	1878	1883	would
O	1884	1886	be
O	1887	1895	referred
O	1896	1899	and
O	1900	1902	73
O	1902	1903	.
O	1903	1904	5
O	1904	1905	%
O	1906	1911	would
O	1912	1915	not
O	1916	1918	be
O	1919	1927	referred
O	1927	1928	.

O	1929	1932	Any
B-Symptom	1933	1937	hard
I-Symptom	1938	1945	exudate
I-Symptom	1946	1952	within
I-Symptom	1953	1956	one
I-Symptom	1957	1961	disc
I-Symptom	1962	1970	diameter
I-Symptom	1971	1973	of
I-Symptom	1974	1977	the
I-Symptom	1978	1985	macular
I-Symptom	1986	1992	center
O	1993	2000	detects
B-Disease	2001	2005	CSME
O	2006	2010	with
O	2011	2022	sensitivity
O	2023	2025	94
O	2025	2026	%
O	2026	2027	,
O	2028	2039	specificity
O	2040	2042	54
O	2042	2043	%
O	2043	2044	.

B-Symptom	2045	2049	Hard
I-Symptom	2050	2057	exudate
I-Symptom	2058	2060	of
I-Symptom	2061	2069	moderate
I-Symptom	2070	2072	or
I-Symptom	2073	2078	worse
I-Symptom	2079	2087	severity
I-Symptom	2088	2096	anywhere
I-Symptom	2097	2099	in
I-Symptom	2100	2103	the
I-Symptom	2104	2111	macular
I-Symptom	2112	2118	region
O	2119	2120	(
O	2120	2125	field
O	2126	2127	2
O	2127	2128	)
O	2129	2137	predicts
B-Disease	2138	2142	CSME
O	2143	2147	with
O	2148	2159	sensitivity
O	2160	2162	89
O	2162	2163	%
O	2163	2164	,
O	2165	2176	specificity
O	2177	2179	58
O	2179	2180	%
O	2180	2181	.

O	2182	2191	Screening
O	2192	2201	protocols
O	2202	2207	based
O	2208	2210	on
O	2211	2220	assessing
B-Symptom	2221	2232	retinopathy
I-Symptom	2233	2239	lesion
O	2240	2248	severity
O	2249	2251	in
O	2252	2255	the
B-Anatomy	2256	2265	posterior
I-Anatomy	2266	2272	fundus
O	2273	2277	have
O	2278	2281	the
O	2282	2291	potential
O	2292	2294	to
O	2295	2303	identify
O	2304	2308	most
B-Disease	2309	2317	diabetic
O	2318	2326	patients
O	2327	2331	with
B-Disease	2332	2338	vision
I-Disease	2338	2339	-
I-Disease	2339	2350	threatening
I-Disease	2351	2362	retinopathy
O	2362	2363	.

O	2364	2366	If
O	2367	2370	the
O	2371	2380	protocols
O	2381	2384	can
O	2385	2387	be
O	2388	2399	implemented
O	2400	2411	effectively
O	2412	2414	in
O	2415	2416	a
O	2417	2424	primary
O	2425	2429	care
O	2430	2437	setting
O	2437	2438	,
O	2439	2447	patients
O	2448	2457	requiring
O	2458	2466	referral
O	2467	2470	for
O	2471	2480	specialty
O	2481	2485	care
O	2486	2491	could
O	2492	2494	be
O	2495	2503	reliably
O	2504	2514	identified
O	2514	2515	,
O	2516	2519	and
O	2520	2523	the
O	2524	2529	total
O	2530	2536	number
O	2537	2539	of
O	2540	2548	patients
O	2549	2556	needing
O	2557	2566	specialty
O	2567	2575	referral
O	2576	2581	could
O	2582	2584	be
O	2585	2598	substantially
O	2599	2606	reduced
O	2607	2611	from
O	2612	2619	current
O	2620	2630	guidelines
O	2630	2631	.
